Article
Exosomes originating from MSCs stimulated with TGF‐β and IFN‐γ promote Treg differentiation
16 Jan 2018
Abstract excerpt
Mesenchymal stem cells (MSCs) have been approved as a cellular drug for the treatment of a variety of immune-related diseases by the government of many countries'. Previous investigations, including ours, have shown that exosomes secreted by MSCs (MSC-ex) are one of the main factors responsible for the therapeutic effect of MSCs. However, the immune modulation activities and the contents of MSC-ex derived from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
